Intensive Care Neurological Disorder
11
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
Early and Objective Assessment of Neurological Prognosis in Cardiac Arrest Patients
A New Approach in Intensive Care Unit Consciousness Assessment: FIVE Score
The Swiss Neurodevelopmental Outcome Registry for Children With CHD
Optimal Brain Oxygenation in Neurologic Intensive Care Unit : The NeurO2 Study
Brazil ICU Encephalitis Surveillance
Experiences and Attitudes Towards Agitated Behaviours in TBI ICU Patients: a Protocol for an Interprofessional Mixed-method Study
Vanderbilt ICU Recovery Program Pilot Trial
Anti-secretory Factor as a Treatment for Adults With Severe Traumatic Head Injury
FEES to Determine Neurological Intensive Care Patients' Oral Diet
Patient and Caregiver Psychological Functioning Following Neuro-ICU Admission: A Prospective Investigation
Pulmonary Physiotherapy for Ischemic Stroke